ID   LPC43
AC   CVCL_A1AQ
DR   Wikidata; Q102114481
RX   PubMed=25784717;
RX   PubMed=32903271;
CC   Characteristics: Established from the patient-derived xenograft PHLC178/ADC6.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 4
//
RX   PubMed=25784717; DOI=10.1158/1541-7786.MCR-14-0165-T;
RA   Wei Y.-H., Vellanki R.N., Coyaud E., Ignatchenko V., Li L., Krieger J.R.,
RA   Taylor P., Tong J.-F., Pham N.-A., Liu G., Raught B., Wouters B.G.,
RA   Kislinger T., Tsao M.-S., Moran M.F.;
RT   "CHCHD2 is coamplified with EGFR in NSCLC and regulates mitochondrial
RT   function and cell migration.";
RL   Mol. Cancer Res. 13:1119-1129(2015).
//
RX   PubMed=32903271; DOI=10.1371/journal.pone.0237981; PMCID=PMC7480864;
RA   Tong J.-F., Krieger J.R., Taylor P., Bagshaw R.D., Kang J., Jeedigunta S.,
RA   Wybenga-Groot L.E., Zhang W., Badr H., Mirhadi S., Pham N.-A.,
RA   Coyaud E., Yu M., Li M., Cabanero M., Raught B., Maynes J.T.,
RA   Hawkins C., Tsao M.-S., Moran M.F.;
RT   "Cancer proteome and metabolite changes linked to SHMT2.";
RL   PLoS ONE 15:E0237981-E0237981(2020).
//